nanovibronix.com (NAOV) - מזומנים למניה אחת

Cash per share demonstrates the liquidity of NanoVibronix, Inc. (NAOV), which develops automated ultrasound wound therapy systems. However, slow physician adoption of the patches and a limited promotional budget are constraining growth. The development of catheters to combat infections is ensuring gradual progress. In the current market environment, the 6.45 metric serves as the target level for the issuer's financial stability.
פילוחי מדדים מקיפים ואנליטיקה עבור nanovibronix.com (NAOV)

To build a high-quality portfolio, I assess liquidity through the ratio of total cash to the number of shares outstanding. This metric reveals hidden capital dilution, which is often masked in infrequent quarterly reports. For NanoVibronix, Inc. (NAOV), this resource is critical as it funds the hiring of engineers to develop wearable ultrasound systems. By analyzing the cash per share, an investor can determine the balance between financial stability and the pace of technological development.